CoChat

Distinguishing Cancer-Associated Missense Mutations from Common Polymorphisms

Kaminker, Joshua S., Zhang, Yan, Waugh, Allison, Haverty, Peter M., Peters, Brock, Sebisanovic, Dragan, Stinson, Jeremy, Forrest, William F., Bazan, J. Fernando, Seshagiri, Somasekar, Zhang, Zemin · 2007 · Cancer Research
Cited by 126

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Missense variants are commonly identified in genomic sequence but only a small fraction directly contribute to oncogenesis. The ability to distinguish those missense changes that contribute to cancer progression from those that do not is a difficult problem usually only accomplished through functional in vivo analyses. Using two computational algorithms, Sorting Intolerant from Tolerant (SIFT) and the Pfam-based LogR.E-value method, we have identified features that distinguish cancer-associated missense mutations from other classes of missense change. Our data reveal that cancer mutants behave similarly to Mendelian disease mutations, but are clearly distinct from either complex disease mutations or common single-nucleotide polymorphisms. We show that both activating and inactivating oncogenic mutations are predicted to be deleterious, although activating changes are likely to increase protein activity. Using the Gene Ontology and data from the SIFT and LogR.E-value metrics, a classifier was built that predicts cancer-associated missense mutations with a very low false-positive rate. The classifier does remarkably well in a number of different experiments designed to distinguish polymorphisms from true cancer-associated mutations. We also show that recurrently observed mutations are much more likely to be predicted to be cancer-associated than rare mutations, suggesting that our classifier will be useful in distinguishing causal from passenger mutations. In addition, from an expressed sequence tag–based screen, we identified a previously unknown germ line change (P1104A) in tumor tissues that is predicted to disrupt the function of the TYK2 protein. The data presented here show that this novel bioinformatics approach to classifying cancer-associated variants is robust and can be used for large-scale analyses. [Cancer Res 2007;67(2):465–73]

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-06-1736

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 126

Metadata

Authors
Kaminker, J. S., Zhang, Y., Waugh, A., Haverty, P. M., Peters, B., Sebisanovic, D., Stinson, J., Forrest, W. F., Bazan, J. F., Seshagiri, S., & Zhang, Z.
Venue
Cancer Research
Published
2007-01-15
Volume
67
Issue
2
Pages
465-473
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W1983728054
Cited by
126
References
4
FWCI
5.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Distinguishing Cancer-Associated Missense Mutations from Common Polymorphisms. https://app.cochat.ai/papers/10.1158/0008-5472.can-06-1736
The paper
Kaminker, J. S., Zhang, Y., Waugh, A., Haverty, P. M., Peters, B., Sebisanovic, D., Stinson, J., Forrest, W. F., Bazan, J. F., Seshagiri, S., & Zhang, Z. (2007). Distinguishing Cancer-Associated Missense Mutations from Common Polymorphisms. Cancer Research. https://doi.org/10.1158/0008-5472.can-06-1736

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.